Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 10/20 | 0.70 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.54 |
| ▸ | CYP17A1 | P05093 | 2/20 | 0.52 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.52 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.52 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
| ▸ | SHBG | P04278 | 1/20 | 0.48 |
| ▸ | SERPINA6 | P08185 | 1/20 | 0.48 |
| ▸ | AR | P10275 | 1/20 | 0.48 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.48 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.47 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.47 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5676587 | 1.00 | CYP19A1 (0.70) | CYP19A1CYP1B1CYP17A1SRD5A1SRD5A2 | |
| SCHEMBL11740332 | 0.90 | CYP19A1 (0.67) | CYP19A1CYP1B1CYP17A1SRD5A1SRD5A2 | |
| SCHEMBL11054544 | 0.87 | CYP19A1 (0.65) | CYP19A1CYP1B1CYP17A1SRD5A1SRD5A2 | |
| SCHEMBL26964891 | 0.87 | CYP19A1 (0.69) | CYP19A1CYP1B1CYP17A1SRD5A1SRD5A2 | |
| SCHEMBL3132563 | 0.87 | CYP19A1 (0.69) | CYP19A1CYP1B1CYP17A1SRD5A1SRD5A2 | |
| SCHEMBL11054839 | 0.86 | CYP19A1 (0.64) | CYP19A1CYP1B1CYP17A1SRD5A1SRD5A2 | |
| SCHEMBL514562 | 0.86 | CYP19A1 (0.64) | CYP19A1CYP1B1CYP17A1SRD5A1SRD5A2 | |
| SCHEMBL3706757 | 0.86 | CYP19A1 (0.67) | CYP19A1CYP1B1CYP17A1SRD5A1SRD5A2 | |
| SCHEMBL11057900 | 0.85 | CYP19A1 (0.63) | CYP19A1CYP1B1CYP17A1SRD5A1SRD5A2 | |
| SCHEMBL5489879 | 0.84 | CYP19A1 (0.61) | CYP19A1CYP1B1CYP17A1SRD5A1SRD5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120025397-A | Synthesis method of pregna-5-ene-3,7,20-trione divinyl ketal | 台州仙琚药业有限公司 | 2025-05-23 | — | — | CN | claimed |
| CN-113583075-B | Preparation method of medroxyprogesterone | 浙江神洲药业有限公司 | 2022-05-20 | — | — | CN | claimed |
| CN-105987978-B | Method that is a kind of while measuring 7 kinds of compounds contents in cortex periplocae | 石家庄以岭药业股份有限公司 | 2019-03-05 | — | — | CN | claimed |
| CN-108239138-A | - 16 α of -16 Beta-methyl of 5- pregnenes, -3 β -ol -20- ketone pharmaceutical intermediate synthetic methods of 17 beta epoxide | 成都奥卡特科技有限公司 | 2018-07-03 | — | — | CN | claimed |
| CN-108239139-A | - 16 α of 5- pregnenes, the synthetic method of -3 β -ol -20- ketone pharmaceutical intermediates of 17 α-epoxy | 成都奥卡特科技有限公司 | 2018-07-03 | — | — | CN | claimed |
| CN-103957998-B | Anti-aging composition for skin | 荷兰联合利华有限公司 | 2018-06-12 | — | — | CN | claimed |
| US-20170360673-A1 | HAIR COMPOSITION | CONOPCO, INC., D/B/A UNILEVER (US) | 2017-12-21 | — | — | US | claimed |
| CN-107106628-A | Hair composition | 荷兰联合利华有限公司 | 2017-08-29 | — | — | CN | claimed |
| CN-103764151-B | CB1 receptor antagonists | 国家医疗保健研究所 | 2017-05-17 | — | — | CN | claimed |
| CN-106537145-A | Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment | 麦特博隆股份有限公司 | 2017-03-22 | — | — | CN | claimed |
| EP-3129909-A1 | SMALL MOLECULE BIOCHEMICAL PROFILING OF INDIVIDUAL SUBJECTS FOR DISEASE DIAGNOSIS AND HEALTH ASSESSMENT | Metabolon, Inc. (US) | 2017-02-15 | — | — | EP | claimed |
| WO-2015157407-A1 | SMALL MOLECULE BIOCHEMICAL PROFILING OF INDIVIDUAL SUBJECTS FOR DISEASE DIAGNOSIS AND HEALTH ASSESSMENT | METABOLON, INC. (US) | 2015-10-15 | — | — | WO | claimed |
| EP-2109618-A1 | NITRIC OXIDE RELEASING STEROIDS | Nicox S.A. (FR) | 2009-10-21 | — | — | EP | claimed |
| WO-2008095809-A1 | NITRIC OXIDE RELEASING STEROIDS | NICOX S.A. (FR) | 2008-08-14 | — | — | WO | claimed |
| EP-1432399-A1 | ENHANCING EPIDERMAL BARRIER DEVELOPMENT IN SKIN | UNILEVER PLC (GB) | 2004-06-30 | — | — | EP | claimed |
| WO-2003030857-A1 | ENHANCING EPIDERMAL BARRIER DEVELOPMENT IN SKIN | UNILEVER PLC (GB) | 2003-04-17 | — | — | WO | claimed |
| CN-121851089-A | Preparation method of fluocalcitriol intermediate | 浙江工业大学 | 2026-04-14 | — | — | CN | disclosed |
| US-12312450-B2 | Dynamically crosslinkable polymeric compositions, articles, and methods thereof | BRASKEM S.A. (BR) | 2025-05-27 | — | — | US | disclosed |
| US-4170518-A | Microbiological conversion of sterol derivatives to 5-androsten-17-one derivatives and their use | SCHERING AKTIENGESELLSCHAFT (DE) | 1979-10-09 | — | — | US | disclosed |
| US-4013688-A | STEROIDS | THE UPJOHN COMPANY (US) | 1977-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170360673-A1 | HAIR COMPOSITION | GLS2, GLS, CYP17A1 | CYP19A1 351/4885CYP1B1 1135/4885CYP17A1 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.